{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:09:16Z","timestamp":1788808156879,"version":"build-2803163510"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016944","name":"Regenerative Medicine Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteogenesis imperfecta (OI) is a heterogeneous group of inherited connective tissue disorders primarily caused by dominant mutations in COL1A1 or COL1A2 that impair type I procollagen folding and secretion. Misfolded collagen accumulates in the endoplasmic reticulum (ER), triggering ER stress and osteoblast dysfunction, and bone fragility. Current pharmacologic therapy focuses on inhibiting bone resorption but has limited efficacy and does not address the underlying biology of the disease. The epigenetic regulator polycomb-repressive complex 2 (PRC2) has emerged as an important regulator of bone formation. Genetic and pharmacologic disruption of PRC2 enhanced osteogenic differentiation in WT cells. Here, we demonstrate that inhibition of the PRC2 through targeting its essential component embryonic ectoderm development (EED) enhances osteogenic differentiation, improves bone architecture in male Col1a2+\/G610C OI mouse models, modulates the integrated stress response (ISR), and improves ER morphology in OI cells. These findings identify EED inhibition as a novel epigenetic strategy to restore collagen homeostasis and improve skeletal integrity in OI.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziag142","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:40:10Z","timestamp":1787398810000},"source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of EED enhances osteogenic differentiation and bone formation: a potential therapeutic strategy for osteogenesis imperfecta"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-4056","authenticated-orcid":false,"given":"Margarita E","family":"Carrasco Jeldres","sequence":"first","affiliation":[{"name":"Department of Clinical Genomics, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8735-8098","authenticated-orcid":false,"given":"Oksana","family":"Pichurin","sequence":"additional","affiliation":[{"name":"Department of Clinical Genomics, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6034-214X","authenticated-orcid":false,"given":"Samantha R","family":"Weaver","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences, University of Wisconsin-Madison , Madison, WI 53706 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6528-8971","authenticated-orcid":false,"given":"Eric","family":"Cheang","sequence":"additional","affiliation":[{"name":"Department of Clinical Genomics, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3700-7138","authenticated-orcid":false,"given":"Leah E","family":"Tokach","sequence":"additional","affiliation":[{"name":"Department of Clinical Genomics, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4464-6108","authenticated-orcid":false,"given":"Jennifer J","family":"Westendorf","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]},{"name":"Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-5368","authenticated-orcid":false,"given":"David R","family":"Deyle","sequence":"additional","affiliation":[{"name":"Department of Clinical Genomics, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]},{"name":"Department of Molecular Medicine, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"2026090715012443900_ref1","first-page":"5241","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"Byers","year":"2000"},{"issue":"2","key":"2026090715012443900_ref2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1172\/JCI115622","article-title":"An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen","volume":"89","author":"Shapiro","year":"1992","journal-title":"J Clin Invest"},{"issue":"5","key":"2026090715012443900_ref3","first-page":"975","article-title":"Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta","volume":"46","author":"Wenstrup","year":"1990","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2026090715012443900_ref4","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"2026090715012443900_ref5","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1371\/journal.pgen.0040007","article-title":"ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta","volume":"4","author":"Lisse","year":"2008","journal-title":"PLoS Genet"},{"issue":"29","key":"2026090715012443900_ref6","doi-asserted-by":"publisher","first-page":"e2201273","DOI":"10.1002\/advs.202201273","article-title":"ER, mitochondria, and ISR regulation by mt-HSP70 and ATF5 upon procollagen misfolding in osteoblasts","volume":"9","author":"Gorrell","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"2026090715012443900_ref7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/jbmr.2824","article-title":"Osteoblast malfunction caused by cell stress response to procollagen misfolding in \u03b12(I)-G610C mouse model of osteogenesis imperfecta","volume":"31","author":"Mirigian","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026090715012443900_ref8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2018.12.111","article-title":"Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta","volume":"509","author":"Scheiber","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"2026090715012443900_ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2017_56","article-title":"Adapting secretory proteostasis and function through the unfolded protein response","volume":"414","author":"Wong","year":"2018","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"2026090715012443900_ref10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.tcb.2010.11.007","article-title":"Chaperoning osteogenesis: new protein-folding disease paradigms","volume":"21","author":"Makareeva","year":"2011","journal-title":"Trends Cell Biol"},{"issue":"7","key":"2026090715012443900_ref11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1242\/jcs.01731","article-title":"Procollagen trafficking, processing and fibrillogenesis","volume":"118","author":"Canty","year":"2005","journal-title":"J Cell Sci"},{"issue":"11","key":"2026090715012443900_ref12","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.bbamcr.2013.04.008","article-title":"A molecular ensemble in the rER for procollagen maturation","volume":"1833","author":"Ishikawa","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"2026090715012443900_ref13","doi-asserted-by":"publisher","first-page":"8283","DOI":"10.1007\/s00018-021-04017-z","article-title":"Noncanonical ER-Golgi trafficking and autophagy of endogenous procollagen in osteoblasts","volume":"78","author":"Gorrell","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"5-6","key":"2026090715012443900_ref14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/03008207.2014.959120","article-title":"Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling","volume":"55","author":"Mirigian","year":"2014","journal-title":"Connect Tissue Res"},{"key":"2026090715012443900_ref15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.matbio.2020.06.002","article-title":"Mechanisms of procollagen and HSP47 sorting during ER-to-Golgi trafficking","volume":"93","author":"Omari","year":"2020","journal-title":"Matrix Biol"},{"issue":"43","key":"2026090715012443900_ref16","doi-asserted-by":"publisher","first-page":"E10099","DOI":"10.1073\/pnas.1814552115","article-title":"Noncanonical autophagy at ER exit sites regulates procollagen turnover","volume":"115","author":"Omari","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9418","key":"2026090715012443900_ref17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"2026090715012443900_ref18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/07853890510007386","article-title":"Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?","volume":"37","author":"Rauch","year":"2005","journal-title":"Ann Med"},{"issue":"7","key":"2026090715012443900_ref19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026090715012443900_ref20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2026090715012443900_ref21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3389\/fendo.2019.00924","article-title":"Management of Osteogenesis Imperfecta","volume":"10","author":"Ralston","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2026090715012443900_ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113439","article-title":"Anti-sclerostin antibodies in osteoporosis and other bone diseases","volume":"9","author":"Fabre","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"2026090715012443900_ref23","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/jcmm.14072","article-title":"Effect of rapamycin on bone mass and strength in the \u03b12(I)-G610C mouse model of osteogenesis imperfecta","volume":"23","author":"Bateman","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2026090715012443900_ref24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149636","article-title":"4PBA reduces growth deficiency in osteogenesis imperfecta by enhancing transition of hypertrophic chondrocytes to osteoblasts","volume":"7","author":"Scheiber","year":"2022","journal-title":"JCI Insight"},{"issue":"5","key":"2026090715012443900_ref25","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.bbadis.2018.02.002","article-title":"4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion","volume":"1864","author":"Besio","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"2026090715012443900_ref26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/jbmr.317","article-title":"Genome-scale techniques highlight the epigenome and redefine fundamental principles of gene regulation","volume":"26","author":"Pike","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026090715012443900_ref27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrendo.2011.234","article-title":"MicroRNA control of bone formation and homeostasis","volume":"8","author":"Lian","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"2026090715012443900_ref28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nrm2298","article-title":"Multivalent engagement of chromatin modifications by linked binding modules","volume":"8","author":"Ruthenburg","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2026090715012443900_ref29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","article-title":"EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency","volume":"32","author":"Shen","year":"2008","journal-title":"Mol Cell"},{"issue":"6","key":"2026090715012443900_ref30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.stem.2008.11.007","article-title":"An EZ mark to miss","volume":"3","author":"Ho","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"13","key":"2026090715012443900_ref31","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1128\/MCB.21.13.4330-4336.2001","article-title":"The polycomb-group gene Ezh2 is required for early mouse development","volume":"21","author":"O'Carroll","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2026090715012443900_ref32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4161\/cc.27921","article-title":"Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis","volume":"13","author":"Marchesi","year":"2014","journal-title":"Cell Cycle"},{"issue":"7265","key":"2026090715012443900_ref33","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature08398","article-title":"Role of the polycomb protein EED in the propagation of repressive histone marks","volume":"461","author":"Margueron","year":"2009","journal-title":"Nature"},{"issue":"33","key":"2026090715012443900_ref34","doi-asserted-by":"publisher","first-page":"12894","DOI":"10.1074\/jbc.RA118.002983","article-title":"Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice","volume":"293","author":"Dudakovic","year":"2018","journal-title":"J Biol Chem"},{"issue":"46","key":"2026090715012443900_ref35","doi-asserted-by":"publisher","first-page":"27604","DOI":"10.1074\/jbc.M115.672345","article-title":"Epigenetic control of skeletal development by the histone methyltransferase Ezh2","volume":"290","author":"Dudakovic","year":"2015","journal-title":"J Biol Chem"},{"issue":"40","key":"2026090715012443900_ref36","doi-asserted-by":"publisher","first-page":"28783","DOI":"10.1074\/jbc.M113.489732","article-title":"Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation","volume":"288","author":"Dudakovic","year":"2013","journal-title":"J Biol Chem"},{"issue":"47","key":"2026090715012443900_ref37","doi-asserted-by":"publisher","first-page":"24594","DOI":"10.1074\/jbc.M116.740571","article-title":"Enhancer of Zeste homolog 2 inhibition stimulates bone formation and mitigates bone loss caused by ovariectomy in skeletally mature mice","volume":"291","author":"Dudakovic","year":"2016","journal-title":"J Biol Chem"},{"issue":"2","key":"2026090715012443900_ref38","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.xpro.2021.100452","article-title":"Primary mouse osteoblast and osteoclast culturing and analysis","volume":"2","author":"Chevalier","year":"2021","journal-title":"STAR Protoc"},{"issue":"5661","key":"2026090715012443900_ref39","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1126\/science.1088757","article-title":"Gene targeting in stem cells from individuals with osteogenesis imperfecta","volume":"303","author":"Chamberlain","year":"2004","journal-title":"Science"},{"issue":"1","key":"2026090715012443900_ref40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/mt.2011.209","article-title":"Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs","volume":"20","author":"Deyle","year":"2012","journal-title":"Mol Ther"},{"issue":"4","key":"2026090715012443900_ref41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nchembio.2306","article-title":"The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex","volume":"13","author":"He","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2026090715012443900_ref42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/00498254.2021.2005852","article-title":"Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment","volume":"52","author":"Zhang","year":"2022","journal-title":"Xenobiotica"},{"issue":"15","key":"2026090715012443900_ref43","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1111\/febs.14963","article-title":"Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes","volume":"286","author":"Besio","year":"2019","journal-title":"FEBS J"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziag142\/70764064\/ziag142.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/10\/ziag142\/70764064\/ziag142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/10\/ziag142\/70764064\/ziag142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:01:29Z","timestamp":1788807689000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziag142\/8768713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziag142","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,22]]},"article-number":"ziag142"}}